Loading...
Header Logo
Keywords
Last Name
Institution

Udho Thadani

TitleProf Emeritus
InstitutionUniversity of Oklahoma Health Sciences Center
DepartmentMedicine Cardiology
Address800 Stanton L Young Blvd
Oklahoma City OK 73104-0001
Phone405/271-4742
vCardDownload vCard

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Thadani U. Routine invasive strategies compared with conservative strategies do not lower the all-cause mortality in patients with non-ST elevation myocardial infarction and unstable angina. Evid Based Med. 2017 Oct; 22(5):190. PMID: 28775170.
      View in: PubMed
    2. Rousan TA, Mathew ST, Thadani U. Drug Therapy for Stable Angina Pectoris. Drugs. 2017 Mar; 77(3):265-284. PMID: 28120185.
      View in: PubMed
    3. Rousan TA, Mathew ST, Thadani U. The risk of cardiovascular side effects with anti-anginal drugs. Expert Opin Drug Saf. 2016 Dec; 15(12):1609-1623. PMID: 27659354.
      View in: PubMed
    4. Thadani U. Management of Stable Angina - Current Guidelines: A Critical Appraisal. Cardiovasc Drugs Ther. 2016 Aug; 30(4):419-26. PMID: 27638354.
      View in: PubMed
    5. Mathew ST, Pakala AV, Thadani U. Invasive strategy in acute coronary syndrome. Lancet. 2016 Jun 18; 387(10037):2503-4. PMID: 27353678.
      View in: PubMed
    6. Patel N, Ju C, Macon C, Thadani U, Schulte PJ, Hernandez AF, Bhatt DL, Butler J, Yancy CW, Fonarow GC. Temporal Trends of Digoxin Use in Patients Hospitalized With Heart Failure: Analysis From the American Heart Association Get With The Guidelines-Heart Failure Registry. JACC Heart Fail. 2016 May; 4(5):348-56. PMID: 26874392.
      View in: PubMed
    7. Patel N, Patel NJ, Thakkar B, Singh V, Arora S, Patel N, Savani C, Deshmukh A, Thadani U, Badheka AO, Alfonso C, Fonarow GC, Cohen MG. Management Strategies and Outcomes of ST-Segment Elevation Myocardial Infarction Patients Transferred After Receiving Fibrinolytic Therapy in the United States. Clin Cardiol. 2016 Jan; 39(1):9-18. PMID: 26785349.
      View in: PubMed
    8. Thadani U, Latif F. Percutaneous coronary interventions in the elderly improve quality of life: evidence far from certain. Cardiology. 2014; 129(1):44-5. PMID: 25096401.
      View in: PubMed
    9. Thadani U. Challenges with nitrate therapy and nitrate tolerance: prevalence, prevention, and clinical relevance. Am J Cardiovasc Drugs. 2014 Aug; 14(4):287-301. PMID: 24664980.
      View in: PubMed
    10. Thadani U, Latif F. Pigment epithelial-derived factor and acute coronary syndrome: a novel protective biomarker but not for routine clinical use at present. Cardiology. 2014; 127(1):28-30. PMID: 24192803.
      View in: PubMed
    11. Golwala HB, Thadani U, Liang L, Stavrakis S, Butler J, Yancy CW, Bhatt DL, Hernandez AF, Fonarow GC. Use of hydralazine-isosorbide dinitrate combination in African American and other race/ethnic group patients with heart failure and reduced left ventricular ejection fraction. J Am Heart Assoc. 2013 Aug 21; 2(4):e000214. PMID: 23966379; PMCID: PMC3828812.
    12. McCullough PA, Barnard D, Clare R, Ellis SJ, Fleg JL, Fonarow GC, Franklin BA, Kilpatrick RD, Kitzman DW, O'Connor CM, Piña IL, Thadani U, Thohan V, Whellan DJ. Anemia and associated clinical outcomes in patients with heart failure due to reduced left ventricular systolic function. Clin Cardiol. 2013 Oct; 36(10):611-20. PMID: 23929781; PMCID: PMC4008125.
    13. Thadani U, Latif F. Retroperitoneal hemorrhage after cardiac catheterization and percutaneous coronary interventions. Cardiology. 2013; 126(1):24-6. PMID: 23860184.
      View in: PubMed
    14. Dasari TW, Golwala H, Koehler M, Wayangankar S, Pakala A, Schechter E, Lozano P, Abu-Fadel MS, Latif F, Thadani U. Is risk factor control and guideline-based medical therapy optimal in patients with nonobstructive coronary artery disease? A Veterans Affairs study. Am J Med Sci. 2013 May; 345(5):339-42. PMID: 23044654.
      View in: PubMed
    15. Stavrakis S, Pakala A, Thomas J, Chaudhry MA, Thadani U. Obesity, brain natriuretic peptide levels and mortality in patients hospitalized with heart failure and preserved left ventricular systolic function. Am J Med Sci. 2013 Mar; 345(3):211-7. PMID: 23422653.
      View in: PubMed
    16. Thadani U. Should ranolazine be used for all patients with ischemic heart disease or only for symptomatic patients with stable angina or for those with refractory angina pectoris? A critical appraisal. Expert Opin Pharmacother. 2012 Dec; 13(17):2555-63. PMID: 23121448.
      View in: PubMed
    17. Thadani U. Osteoprotegerin and ST segment myocardial infarction: a novel risk marker but not for routine use at present. Cardiology. 2012; 123(2):91-3. PMID: 23018624.
      View in: PubMed
    18. Boden WE, Finn AV, Patel D, Peacock WF, Thadani U, Zimmerman FH. Nitrates as an integral part of optimal medical therapy and cardiac rehabilitation for stable angina: review of current concepts and therapeutics. Clin Cardiol. 2012 May; 35(5):263-71. PMID: 22528319.
      View in: PubMed
    19. Thadani U, Wittig T. A randomized, double-blind, placebo-controlled, crossover, dose-ranging multicenter study to determine the effect of sublingual nitroglycerin spray on exercise capacity in patients with chronic stable angina. Clin Med Insights Cardiol. 2012; 6:87-95. PMID: 22566749; PMCID: PMC3342022.
    20. Piller LB, Baraniuk S, Simpson LM, Cushman WC, Massie BM, Einhorn PT, Oparil S, Ford CE, Graumlich JF, Dart RA, Parish DC, Retta TM, Cuyjet AB, Jafri SZ, Furberg CD, Saklayen MG, Thadani U, Probstfield JL, Davis BR. Long-term follow-up of participants with heart failure in the antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT). Circulation. 2011 Oct 25; 124(17):1811-8. PMID: 21969009; PMCID: PMC3217334.
    21. Stavrakis S, Lazzara R, Thadani U. The benefit of cardiac resynchronization therapy and QRS duration: a meta-analysis. J Cardiovasc Electrophysiol. 2012 Feb; 23(2):163-8. PMID: 21815961.
      View in: PubMed
    22. Gardner AW, Montgomery PS, Ritti-Dias RM, Thadani U. Exercise performance, physical activity, and health-related quality of life in participants with stable angina. Angiology. 2011 Aug; 62(6):461-6. PMID: 21421630; PMCID: PMC3736352.
    23. Stavrakis S, Stoner JA, Azar M, Wayangankar S, Thadani U. Low-dose aspirin for primary prevention of cardiovascular events in patients with diabetes: a meta-analysis. Am J Med Sci. 2011 Jan; 341(1):1-9. PMID: 21191260.
      View in: PubMed
    24. Keteyian SJ, Isaac D, Thadani U, Roy BA, Bensimhon DR, McKelvie R, Russell SD, Hellkamp AS, Kraus WE. Safety of symptom-limited cardiopulmonary exercise testing in patients with chronic heart failure due to severe left ventricular systolic dysfunction. Am Heart J. 2009 Oct; 158(4 Suppl):S72-7. PMID: 19782792; PMCID: PMC2762951.
    25. Patel JH, Stoner JA, Owora A, Mathew ST, Thadani U. Evidence for using clopidogrel alone or in addition to aspirin in post coronary artery bypass surgery patients. Am J Cardiol. 2009 Jun 15; 103(12):1687-93. PMID: 19539077.
      View in: PubMed
    26. Thadani U. Treatment with statins in high-risk patients: relevance of time to titration of dose and adverse outcomes. Am J Cardiovasc Drugs. 2009; 9(3):211-2; author reply 212. PMID: 19463025.
      View in: PubMed
    27. Thadani U, Jacob RG. Isosorbide dinitrate/hydralazine: its role in the treatment of heart failure. Drugs Today (Barc). 2008 Dec; 44(12):925-37. PMID: 19198701.
      View in: PubMed
    28. Black HR, Davis B, Barzilay J, Nwachuku C, Baimbridge C, Marginean H, Wright JT, Basile J, Wong ND, Whelton P, Dart RA, Thadani U. Metabolic and clinical outcomes in nondiabetic individuals with the metabolic syndrome assigned to chlorthalidone, amlodipine, or lisinopril as initial treatment for hypertension: a report from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). Diabetes Care. 2008 Feb; 31(2):353-60. PMID: 18000186.
      View in: PubMed
    29. Thadani U, Ripley TL. Side effects of using nitrates to treat heart failure and the acute coronary syndromes, unstable angina and acute myocardial infarction. Expert Opin Drug Saf. 2007 Jul; 6(4):385-96. PMID: 17688382.
      View in: PubMed
    30. Thadani U, Rodgers T. Side effects of using nitrates to treat angina. Expert Opin Drug Saf. 2006 Sep; 5(5):667-74. PMID: 16907656.
      View in: PubMed
    31. Leenen FH, Nwachuku CE, Black HR, Cushman WC, Davis BR, Simpson LM, Alderman MH, Atlas SA, Basile JN, Cuyjet AB, Dart R, Felicetta JV, Grimm RH, Haywood LJ, Jafri SZ, Proschan MA, Thadani U, Whelton PK, Wright JT. Clinical events in high-risk hypertensive patients randomly assigned to calcium channel blocker versus angiotensin-converting enzyme inhibitor in the antihypertensive and lipid-lowering treatment to prevent heart attack trial. Hypertension. 2006 Sep; 48(3):374-84. PMID: 16864749.
      View in: PubMed
    32. Thadani U. Selection of optimal therapy for chronic stable angina. Curr Treat Options Cardiovasc Med. 2006 Feb; 8(1):23-35. PMID: 16401381.
      View in: PubMed
    33. Vicari RM, Chaitman B, Keefe D, Smith WB, Chrysant SG, Tonkon MJ, Bittar N, Weiss RJ, Morales-Ballejo H, Thadani U. Efficacy and safety of fasudil in patients with stable angina: a double-blind, placebo-controlled, phase 2 trial. J Am Coll Cardiol. 2005 Nov 15; 46(10):1803-11. PMID: 16286163.
      View in: PubMed
    34. Abrams J, Thadani U. Therapy of stable angina pectoris: the uncomplicated patient. Circulation. 2005 Oct 11; 112(15):e255-9. PMID: 16216965.
      View in: PubMed
    35. Whelton PK, Barzilay J, Cushman WC, Davis BR, Iiamathi E, Kostis JB, Leenen FH, Louis GT, Margolis KL, Mathis DE, Moloo J, Nwachuku C, Panebianco D, Parish DC, Pressel S, Simmons DL, Thadani U. Clinical outcomes in antihypertensive treatment of type 2 diabetes, impaired fasting glucose concentration, and normoglycemia: Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). Arch Intern Med. 2005 Jun 27; 165(12):1401-9. PMID: 15983290.
      View in: PubMed
    36. Thadani U. Can nicorandil treat angina pectoris effectively? Nat Clin Pract Cardiovasc Med. 2005 Apr; 2(4):186-7. PMID: 16265479.
      View in: PubMed
    37. Thadani U. Modified-release formulation of trimetazidine for exceptional control of angina pectoris: fact or fiction. Am J Cardiovasc Drugs. 2005; 5(5):331-4. PMID: 16156689.
      View in: PubMed
    38. Thadani U. Current medical management of chronic stable angina. J Cardiovasc Pharmacol Ther. 2004 Sep; 9 Suppl 1:S11-29; quiz S98-9. PMID: 15378129.
      View in: PubMed
    39. Thadani U. Prevention of nitrate tolerance with angiotensin II receptor type 1 blocker in patients with stable angina: yet another failed strategy to prevent tolerance. Cardiovasc Drugs Ther. 2004 Sep; 18(5):339-42. PMID: 15717134.
      View in: PubMed
    40. Thadani U. Recurrent and refractory angina following revascularization procedures in patients with stable angina pectoris. Coron Artery Dis. 2004 May; 15 Suppl 1:S1-4. PMID: 15179121.
      View in: PubMed
    41. Pepine CJ, Rouleau JL, Annis K, Ducharme A, Ma P, Lenis J, Davies R, Thadani U, Chaitman B, Haber HE, Freedman SB, Pressler ML, Pitt B. Effects of angiotensin-converting enzyme inhibition on transient ischemia: the Quinapril Anti-Ischemia and Symptoms of Angina Reduction (QUASAR) trial. J Am Coll Cardiol. 2003 Dec 17; 42(12):2049-59. PMID: 14680725.
      View in: PubMed
    42. Fox KM, Thadani U, Ma PT, Nash SD, Keating Z, Czorniak MA, Gillies H, Keltai M. Sildenafil citrate does not reduce exercise tolerance in men with erectile dysfunction and chronic stable angina. Eur Heart J. 2003 Dec; 24(24):2206-12. PMID: 14659772.
      View in: PubMed
    43. Pepine CJ, Cooper-DeHoff RM, Weiss RJ, Koren M, Bittar N, Thadani U, Minkwitz MC, Michelson EL, Hutchinson HG. Comparison of effects of nisoldipine-extended release and amlodipine in patients with systemic hypertension and chronic stable angina pectoris. Am J Cardiol. 2003 Feb 01; 91(3):274-9. PMID: 12565082.
      View in: PubMed
    44. Thadani U, Smith W, Nash S, Bittar N, Glasser S, Narayan P, Stein RA, Larkin S, Mazzu A, Tota R, Pomerantz K, Sundaresan P. The effect of vardenafil, a potent and highly selective phosphodiesterase-5 inhibitor for the treatment of erectile dysfunction, on the cardiovascular response to exercise in patients with coronary artery disease. J Am Coll Cardiol. 2002 Dec 04; 40(11):2006-12. PMID: 12475462.
      View in: PubMed
    45. Thadani U. Selective L-type, T-type, and nonspecific calcium-channel blockers for stable angina pectoris. Am Heart J. 2002 Jul; 144(1):8-10. PMID: 12094182.
      View in: PubMed
    46. Philbin EF, Hunsberger S, Garg R, Lader E, Thadani U, McSherry F, Silver MA. Usefulness of clinical information to distinguish patients with normal from those with low ejection fractions in heart failure. Am J Cardiol. 2002 May 15; 89(10):1218-21. PMID: 12008182.
      View in: PubMed
    47. Kostis JB, Dockens RC, Thadani U, Bethala V, Pepine C, Leimbach W, Vachharajani N, Raymond RH, Stouffer BC, Tay LK, Shyu WC, Liao WC. Comparison of pharmacokinetics of lanoteplase and alteplase during acute myocardial infarction. Clin Pharmacokinet. 2002; 41(6):445-52. PMID: 12074692.
      View in: PubMed
    Thadani's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    _
    Co-Authors Expand Description
    _
    Similar People Expand Description
    _
    Same Department Expand Description
    Physical Neighbors Expand Description
    _